Company Overview
Snapshot
Founded in January 2016 by Igal Liapis and Dadi Segal, Prudentix operates with 1–10 employees. The company focuses on developing chemical medical devices for oral care and dentistry, holding a patent for its formulations.
Business overview
Prudentix is an R&D company specializing in the development of chemical medical devices for oral care and dentistry. The company's core technology involves patented formulations with physico-chemical properties, anti-inflammatory, and healing actions, targeting conditions such as periodontal pockets, gingivitis, halitosis, and general oral hygiene. Prudentix manufactures liquid and semi-solid products, as well as films, tablets, and sprays, adhering to strict quality standards including ISO 13485 for medical devices, ISO 22716 for cosmetics, and ISO 9001. It serves both B2C and B2B markets globally within the Health Tech & Life Sciences sector, specifically in Medical Devices and Pharma & Medical Biotechnology.
Log in to access full profile ›Company Intelligence Q&A
- What is Prudentix's primary focus?
- Prudentix is an R&D company dedicated to developing chemical medical devices for oral care and dentistry, addressing issues like periodontal pockets, gingivitis, and halitosis.
- Who founded Prudentix?
- Prudentix was co-founded by Igal Liapis and Dadi Segal in January 2016.
- What quality standards does Prudentix adhere to for its products?
- Prudentix manufactures its products under strict quality standards, including ISO 13485 for medical devices, ISO 22716 for cosmetics, and ISO 9001 for general operational quality.
- What types of products does Prudentix offer?
- Prudentix offers products such as Perio Dent, Aphthron, and Pocket X, which are patented formulations designed for various oral health applications.
- In which markets does Prudentix operate?
- Prudentix operates in global markets, serving both B2C and B2B customers with its dental care products.